LiverMultiScan shown to be a cost-effective alternative to liver biopsies for monitoring patients with autoimmune hepatitis
Health economics study estimates significant savings for England’s NHS
Oxford, U.K. — September 21, 2022. A health economic study performed by NHS England’s Oxford Academic Health Science Network (AHSN) showed that Perspectum’s LiverMultiScan — an artificial intelligence-enhanced, noninvasive liver health diagnostic tool — is a cost-effective alternative to painful, invasive liver biopsies for monitoring disease activity and treatment response in patients with autoimmune hepatitis (AIH).